How much funding has Pretzel Therapeutics raised?

Pretzel Therapeutics has raised $131.8M in total funding, most recently a Venture Round.

Who are Pretzel Therapeutics's investors?

Pretzel Therapeutics's investors include ARCH Venture Partners, Mubadala Capital, HealthCap, Cambridge Innovation Capital, EIR Ventures, GV.

When was Pretzel Therapeutics founded?

Pretzel Therapeutics was founded in 2022.

Where is Pretzel Therapeutics headquartered?

Pretzel Therapeutics is headquartered in Waltham, Massachusetts, United States.

What industry is Pretzel Therapeutics in?

Pretzel Therapeutics operates in Biotech, Drug Discovery, Genomics, Therapeutics.

How many employees does Pretzel Therapeutics have?

Pretzel Therapeutics has 11-50 employees.

Pretzel Therapeutics

Waltham, United States · Founded 2022 · $131.8M raised

Headquarters: Waltham, Massachusetts
Employees: 11–50
Founded: 2022
Business Model: B2B

Website: pretzeltx.com
Total Funding: $131.8M
Last Round: $59.3M Venture RoundAug 2024
Rounds: 2

About

Pretzel Therapeutics is a clinical-stage biotech company developing small molecule therapies that target mitochondrial biology to treat metabolic diseases, rare mitochondrial disorders, and aging-related conditions. The company's lead program PX578 entered Phase 1 clinical trials in 2025, targeting POLRMT as a novel mechanism for metabolic disease treatment. Pretzel collaborates with leading research institutions including SciLifeLab to advance mitochondrial drug discovery.

Summary

Pretzel Therapeutics is a Biotech company based in Waltham, United States, founded in 2022. It has raised $131.8M in total across 2 rounds, most recently a $59.3M Venture Round round in Aug 2024. Investors include ARCH Venture Partners, Mubadala Capital and HealthCap.